25.60 M
About CO.DON AG INH. O.N.
Sector
Industry
CEO
Ying Zhou
Website
Headquarters
Teltow
Founded
1999
ISIN
DE000A3E5C08
FIGI
BBG000DRFST6
co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage defects. Its customers include accident surgeons, orthopaedic surgeons, and neurosurgeons in clinics and specialised practices. The firms main product Spherox is a three-dimensional chondrocyte product used to treat articular cartilage defects in the knee with autologous cells by means of matrix-associated autologous chondrocyte transplantation. The company was founded in 1993 and is headquartered in Teltow, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CO.DON AG INH. O.N. stocks are traded under the ticker CNW.
CO.DON AG INH. O.N. is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track CO.DON AG INH. O.N. financials in yearly and quarterly reports right on TradingView.
Like other stocks, CNW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CO.DON AG INH. O.N. stock right from TradingView charts — choose your broker and connect to your account.